statistiche ricercatore

Nome	#
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes	200
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia	164
DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION	122
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA.	111
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4	106
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS	83
Consistency Of RQPCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View	79
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia	78
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor	67
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients	58
Totale	1.068

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	45	0	0	0	0	0	0	0	0	0	0	32	13
2019/2020	114	9	7	5	14	5	22	13	3	10	14	6	6
2020/2021	129	6	10	8	2	23	1	12	5	7	2	23	30
2021/2022	155	16	4	3	9	7	4	13	10	7	6	45	31
2022/2023	248	23	23	6	35	21	49	9	21	33	13	12	3
2023/2024	71	11	21	7	2	5	11	2	6	0	3	3	0
Totale													1.068

CINECA IRIS Institutional Research Information System